HJIM
Henry James International Management’s Ascendis Pharma ASND Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.75M | Sell |
15,956
-1,895
| -11% | -$327K | 0.91% | 36 |
|
2025
Q1 | $2.78M | Hold |
17,851
| – | – | 0.95% | 34 |
|
2024
Q4 | $2.46M | Sell |
17,851
-3,500
| -16% | -$482K | 0.88% | 34 |
|
2024
Q3 | $3.19M | Sell |
21,351
-3,146
| -13% | -$470K | 1.11% | 32 |
|
2024
Q2 | $3.34M | Sell |
24,497
-24
| -0.1% | -$3.27K | 1.18% | 31 |
|
2024
Q1 | $3.71M | Buy |
24,521
+26
| +0.1% | +$3.93K | 1.14% | 27 |
|
2023
Q4 | $3.09M | Hold |
24,495
| – | – | 1.16% | 28 |
|
2023
Q3 | $2.29M | Hold |
24,495
| – | – | 0.99% | 34 |
|
2023
Q2 | $2.19M | Sell |
24,495
-1,522
| -6% | -$136K | 0.95% | 31 |
|
2023
Q1 | $2.79M | Sell |
26,017
-6
| -0% | -$643 | 1.18% | 27 |
|
2022
Q4 | $3.18M | Hold |
26,023
| – | – | 1.54% | 25 |
|
2022
Q3 | $2.69M | Buy |
26,023
+2,701
| +12% | +$279K | 1.5% | 25 |
|
2022
Q2 | $2.17M | Sell |
23,322
-6,400
| -22% | -$595K | 1.09% | 31 |
|
2022
Q1 | $3.49M | Sell |
29,722
-7,177
| -19% | -$842K | 1.37% | 27 |
|
2021
Q4 | $4.96M | Hold |
36,899
| – | – | 1.53% | 23 |
|
2021
Q3 | $5.88M | Buy |
36,899
+1,355
| +4% | +$216K | 1.85% | 16 |
|
2021
Q2 | $4.68M | Buy |
35,544
+60
| +0.2% | +$7.89K | 1.34% | 23 |
|
2021
Q1 | $4.57M | Sell |
35,484
-3,299
| -9% | -$425K | 1.38% | 22 |
|
2020
Q4 | $6.47M | Hold |
38,783
| – | – | 2.25% | 12 |
|
2020
Q3 | $5.99M | Buy |
38,783
+1
| +0% | +$154 | 2.44% | 9 |
|
2020
Q2 | $5.74M | Buy |
38,782
+18,413
| +90% | +$2.72M | 2.4% | 8 |
|
2020
Q1 | $2.29M | Buy |
20,369
+11,962
| +142% | +$1.35M | 1.18% | 27 |
|
2019
Q4 | $1.17M | Sell |
8,407
-4,500
| -35% | -$626K | 0.45% | 60 |
|
2019
Q3 | $1.24M | Buy |
12,907
+4,500
| +54% | +$433K | 0.53% | 48 |
|
2019
Q2 | $968K | Buy |
8,407
+4,900
| +140% | +$564K | 0.42% | 62 |
|
2019
Q1 | $413K | Buy |
+3,507
| New | +$413K | 0.19% | 104 |
|